5 Best Healthcare Dividend Stocks to Buy Now

2. Gilead Sciences, Inc. (NASDAQ: GILD)

Number of Hedge Fund Holders: 65
Dividend Yield: 4%

Gilead Sciences, Inc. (NASDAQ: GILD) is a research-centric biopharmaceutical company that works to develop and commercialize medicines in areas of unmet medical need in the US, Europe, and across the globe. The company offers products to treat human immunodeficiency virus (HIV) infections and to treat coronavirus, among other products. It ranks 2nd on our list of the best healthcare dividend stocks to buy now.

BMO Capital’s Matthew Luchini just this July raised his price target on shares of Gilead Sciences, Inc. (NASDAQ: GILD) from $67 to $72. The analyst holds a Market Perform rating on the stock as well.

In the second quarter of 2021, Gilead Sciences, Inc. (NASDAQ: GILD) had an EPS of $1.87, beating estimates by $0.12. The company’s revenue was $6.22 billion, up 20.88% year over year and beating estimates by $133.06 million. Gilead Sciences, Inc. (NASDAQ: GILD) has gained 10.15% in the past 6 months and 19.3% year to date.

By the end of the first quarter of 2021, 65 hedge funds out of the 866 tracked by Insider Monkey held stakes in Gilead Sciences, Inc. (NASDAQ: GILD) worth roughly $2.7 billion. This is compared to 72 hedge funds in the previous quarter with a total stake value of approximately $2.02 billion.